Assessing phage-host population dynamics by reintroducing virulent viruses to synthetic microbiomes.

bacteriophages colony isolation crAssphage dilution gut microbiota lytic prophage synthetic communities virome virulent

Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
18 Apr 2024
Historique:
received: 29 09 2023
revised: 31 01 2024
accepted: 01 04 2024
medline: 24 4 2024
pubmed: 24 4 2024
entrez: 23 4 2024
Statut: aheadofprint

Résumé

Microbiomes feature complex interactions between diverse bacteria and bacteriophages. Synthetic microbiomes offer a powerful way to study these interactions; however, a major challenge is obtaining a representative bacteriophage population during the bacterial isolation process. We demonstrate that colony isolation reliably excludes virulent viruses from sample sources with low virion-to-bacteria ratios such as feces, creating "virulent virus-free" controls. When the virulent dsDNA virome is reintroduced to a 73-strain synthetic gut microbiome in a bioreactor model of the human colon, virulent viruses target susceptible strains without significantly altering community structure or metabolism. In addition, we detected signals of prophage induction that associate with virulent predation. Overall, our findings indicate that dilution-based isolation methods generate synthetic gut microbiomes that are heavily depleted, if not devoid, of virulent viruses and that such viruses, if reintroduced, have a targeted effect on community assembly, metabolism, and prophage replication.

Identifiants

pubmed: 38653241
pii: S1931-3128(24)00114-8
doi: 10.1016/j.chom.2024.04.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests E.A.-V. is the co-founder and CSO of NuBiyota LLC & Company that is working to commercialize human gut-derived microbial communities for medical applications.

Auteurs

Jacob Wilde (J)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada.

Randy Boyes (R)

Queen's University, Department of Community Health and Epidemiology, Kingston, ON K7L 3N6, Canada.

Avery V Robinson (AV)

University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford OX3 7FY, UK.

Brendan A Daisley (BA)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada.

Alexander J Botschner (AJ)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada.

Dylan J L Brettingham (DJL)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada.

Christine V Macpherson (CV)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada.

Elizabeth Mallory (E)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada.

Emma Allen-Vercoe (E)

University of Guelph, Department of Molecular and Cellular Biology, Guelph, ON N1G 2W1, Canada. Electronic address: eav@uoguelph.ca.

Classifications MeSH